Skip to main content
Clinical Trials/CTRI/2019/07/020288
CTRI/2019/07/020288
Completed
Phase 4

Comparison of Intrathecal Hyperbaric Ropivacaine 0.5% with and without 75 mg of Magnesium Sulphate as an adjuvant for Infraumblical Surgeries-A Double Blind Randomised Clinical Trial

Mahatma Gandhi Medical Collage and Research Institute0 sites80 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: O- Medical and SurgicalHealth Condition 2: O- Medical and Surgical
Sponsor
Mahatma Gandhi Medical Collage and Research Institute
Enrollment
80
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
November 2, 2019
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Mahatma Gandhi Medical Collage and Research Institute

Eligibility Criteria

Inclusion Criteria

  • ASA 1 and 2 patients,
  • Patients posted for all infraumblical surgeries of approximatly 2 hours duration,
  • Minimal expected bloods loss surgeries.

Exclusion Criteria

  • Patient unwilling to participate,
  • Pregnant and breast feeding mothers,
  • Patient with coagulation or bleeding disorders,
  • Local spinal site infection,
  • Spinal abnormalities or spinal instrumentation procedures,
  • Patient posted for surgeries for more than 2 hours duration,
  • Patients with unstable hemodynamics.

Outcomes

Primary Outcomes

Not specified

Similar Trials